Allogeneic hematopoietic stem cell transplantation
Showing 26 - 50 of >10,000
Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Trial
Not yet recruiting
- Acute Myeloid Leukaemia (AML)
- +2 more
- (no location specified)
Sep 6, 2022
Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell
Recruiting
- Hematologic Diseases
- COVID-19 vaccine(donor)
- COVID-19 vaccine(patient)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 8, 2022
Hematologic Diseases Trial in Hefei (allogeneic ?9d2 T Cells, Fludarabine, Cyclophosphamide)
Recruiting
- Hematologic Diseases
- allogeneic γ9δ2 T Cells
- +3 more
-
Hefei, Anhui, ChinaAnhui Provincial Hospital
Feb 23, 2023
Hematologic Diseases, Tumors Trial in Hangzhou (CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation)
Recruiting
- Hematologic Diseases
- Neoplasms
- CD7 CAR-T cells injection
- Allogeneic hematopoietic stem cell transplantation
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Apr 11, 2023
Allogeneic Hematopoietic Stem Cell Transplantation in Reunion
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- questionnaire
-
Saint-Pierre, FranceCHU de la Réunion
Apr 14, 2022
Immune Reconstitution to CMV After HSCT: Impact of Clinical
Enrolling by invitation
- CMV Infection
- Hematopoietic Stem Cell Transplantation
-
Beijing, Beijing, China
- +1 more
Jan 5, 2023
CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)
Not yet recruiting
- CMV Infection
- +2 more
- Virus specific T cells
- (no location specified)
Oct 4, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 10, 2023
Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Total-Body Irradiation
- +5 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022
DNA Methylation in Allogeneic Hematopoietic Stem Cell
Recruiting
- Aging
- Stem Cell Transplant Complications
-
Bologna, BO, ItalySt.Orsola-Malpighi University Hospital
Mar 18, 2022
Multiple Myeloma Trial in Hackensack (Fludarabine monophosphate, melphalan, Bortezomib)
Completed
- Multiple Myeloma
- Fludarabine monophosphate, melphalan, Bortezomib
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Apr 29, 2022
Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)
Active, not recruiting
- Relapsed Adult ALL
- Relapsed Adult AML
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 19, 2023
Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute
Recruiting
- Chronic Graft vs Host Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,
Recruiting
- Severe Aplastic Anemia
- MDS (Myelodysplastic Syndrome)
- Miltenyi CD34 Reagent System
- Donor derived G-CSF mobilized PBC
-
Baltimore, Maryland
- +2 more
Jan 25, 2023
Leukemia, Lymphoid Trial in Chengdu (blinatumomab)
Not yet recruiting
- Leukemia, Lymphoid
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Oct 3, 2023
T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023
Lymphoma, Leukemia Trial (Acalabrutinib, tacrolimus, methotrexate)
Withdrawn
- Lymphoma
- Leukemia
- Acalabrutinib, tacrolimus, methotrexate
- (no location specified)
Feb 20, 2022
Digital Droplet PCR in Early Period After Allo-HSCT to Predict
Completed
- Measurable Residual Disease
- Digital Droplet PCR
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 17, 2023
Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia
Recruiting
- Acute Leukemia
- No intervention, observation study
-
Hangzhou, Zhejiang, ChinaClinical research ethics committee of the first affiliated hospi
Oct 6, 2023
Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)
Recruiting
- Chronic Granulomatous Disease
- Sirolimus
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 23, 2022
The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or
Recruiting
- Acute Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 28, 2022
Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)
Not yet recruiting
- Hematologic Diseases
- +2 more
- haplo-SCT with PTCy
- (no location specified)
Nov 8, 2021
Hematologic Tumors Trial in France (Allogeneic (Allo) hematopoietic stem cell transplantation)
Completed
- Hematologic Neoplasms
- Allogeneic (Allo) hematopoietic stem cell transplantation
-
Amiens, France
- +13 more
Jan 27, 2023
Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)
Recruiting
- Myeloid Malignancies
- fractionated busulfan-based conditioning regimen
-
Chendu, Sichuan, ChinaWest China Hospital, Sichuan University
Mar 29, 2023